Accessibility StatementSkip Navigation WUXI, China, Sept. 17, 2025 /PRNewswire/ --Â WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi – MFG1, MFG2, and DP5 – have received GMP certification from Türkiye laç ve Tbbi Cihaz Kurumu (TITCK). This marks the first GMP inspection conducted by Turkey's TITCK at WuXi Biologics. Achieving the certification underscores the company's commitment t ...